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Relapsing polychondritis (RP) is a rare disease character-
ized by recurrent inflammation and destruction of carti-
laginous structures and connective tissue. Extensive organ
involvement can be seen. It is a generally progressive dis-
ease commonly involving the respiratory tract (>50%)
and airway involvement is a major cause of death in RP.
We report a case of a 58-year old man diagnosed with RP
in accordance with the modified diagnostic criteria of
Damiani and Levine, whose clinical features included a
severe respiratory tract chondritis. He was initially treated
with NSAID and intramuscular methylprednisolone. Four
weeks later a lack of response to the treatment and pro-
gressive respiratory involvement resulted in shifting him
to oral prednisone (40–60 mg/daily) and gradual weekly
reduction was planned, until a tapering dose could be
reached. The patient however continued to have severe
intermittent exacerbations of respiratory distress and was
shortly hereafter hospitalized. Conventional therapy had
little effect. Methotrexate was instituted and intravenous
methylpredisolone pulse therapy (500 mg/daily) was
given over a period of 3 days. The patients respiratory
symptoms ameliorated remarkably rapidly and the
patient continued the lower dose prednisone and meth-
otrexate. No short term adverse reactions due to the pulse
therapy were observed. Referral was made for an elective
placement of a tracheo-bronchial stent due to the exten-
sive airway involvement.
Pulse steroid therapy is a concept with a high daily dose of
intravenous steroids over a short span of time (usually 1–
5 days) and several regimens have been described. Doses
of each pulse are not standardized but are usually 5–20
mg/kg for methylprednisolone (250–1000 mg). In most
indications it is usually accompanied by continuous
administration of lower dose steroids and immunosup-
pressive agents.
Pulse steroid therapy has been reported successful in treat-
ing patients with severe manifestations, where rapid
immunosuppression and anti-inflammatory effect is
desired. In RP it may especially be helpful in acute airway
obstruction and may allow stent placement (or tracheot-
omy) to be performed electively. Although it is considered
cumulatively less toxic than sustained low dose steroid
therapy significant adverse reactions may still occur. It
should therefore be used in selected cases under careful
monitoring.
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